Cataloging recent advances in epigenetic alterations in major mental disorders and autism

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Abdolmaleky HM, Zhou JR, Thiagalingam S. An update on the epigenetics of psychotic disorders and autism. Epigenomics 7(3), 427–449 (2015).
  CASGoogle Scholar
• 2. Alam R, Abdolmaleky HM, Zhou JR. Microbiome, inflammation, epigenetic alterations, and mental disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 174(6), 651–660 (2017).
  Medline CASGoogle Scholar
• 3. Abdolmaleky HM, Cheng KH, Russo A et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134B(1), 60–66 (2005).
  MedlineGoogle Scholar
• 4. Grayson DR, Jia X, Chen Y et al. Reelin promoter hypermethylation in schizophrenia. Proc. Natl Acad. Sci. USA 102(26), 9341–9346 (2005).
  Medline CASGoogle Scholar
• 5. Aberg KA, Mcclay JL, Nerella S et al. Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults. JAMA Psychiatry 71(3), 255–264 (2014). • Among the largest whole-genome DNA methylation profiling of blood cell using the technology of next-generation sequencing in schizophrenia (SCZ).
  Medline CASGoogle Scholar
• 6. Nabil Fikri RM, Norlelawati AT, Nour El-Huda AR et al. Reelin (RELN) DNA methylation in the peripheral blood of schizophrenia. J. Psychiatr. Res. 88, 28–37 (2017).
  MedlineGoogle Scholar
• 7. Li Y, Wang K, Zhang P et al. Quantitative DNA methylation analysis of DLGAP2 gene using pyrosequencing in schizophrenia with Tardive Dyskinesia: a linear mixed model approach. Sci. Rep. 8(1), 17466 (2018).
  MedlineGoogle Scholar
• 8. Tao R, Davis KN, Li C, Shin JH et al. GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia. Mol. Psychiatry 23(6), 1496–1505 (2018).
  Medline CASGoogle Scholar
• 9. Abdolmaleky HM, Cheng KH, Faraone SV et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet. 15(21), 3132–3145 (2006).
  Medline CASGoogle Scholar
• 10. Nohesara S, Ghadirivasfi M, Mostafavi S et al. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J. Psychiatr. Res. 45(11), 1432–1438 (2011).
  MedlineGoogle Scholar
• 11. Walton E, Liu J, Hass J et al. MB-COMT promoter DNA methylation is associated with working-memory processing in schizophrenia patients and healthy controls. Epigenetics 9(8), 1101–1107 (2014).
  MedlineGoogle Scholar
• 12. Nour El Huda AR, Norsidah KZ, Nabil Fikri MR, Hanisah MN, Kartini A, Norlelawati AT. DNA methylation of membrane-bound catechol-O-methyltransferase in Malaysian schizophrenia patients. Psychiatry Clin. Neurosci. 72(4), 266–279 (2018).
  MedlineGoogle Scholar
• 13. Abdolmaleky HM, Gower AC, Wong CK et al. Aberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality/asymmetry in schizophrenia and bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 180(2), 138–149 (2019).
  Medline CASGoogle Scholar
• 14. Pai S, Li P, Killinger B et al. Differential methylation of enhancer at IGF2 is associated with abnormal dopamine synthesis in major psychosis. Nat. Commun. 10(1), 2046 (2019). • An interesting epigenetic study showing DNA hypomethylation of IGF2 is linked to increase in dopamine synthesis in psychotic disorders.
  MedlineGoogle Scholar
• 15. Gao J, Yi H, Tang X et al. DNA Methylation and Gene Expression of Matrix Metalloproteinase 9 Gene in Deficit and Non-deficit Schizophrenia. Front. Genet. 11(9), 646 (2018).
  Google Scholar
• 16. Zhou C, Chen J, Tang X et al. DNA methylation and gene expression of the chemokine (C-X-C motif) ligand 1 in patients with deficit and non-deficit schizophrenia. Psychiatry Res. 268, 82–86 (2018).
  Medline CASGoogle Scholar
• 17. Bang M, Kang JI, Kim SJ et al. Reduced DNA methylation of the oxytocin receptor gene is associated with anhedonia-asociality in women with recent-onset schizophrenia and ultra-high risk for psychosis. Schizophr. Bull. 45(6), 1279–1290 (2019).
  MedlineGoogle Scholar
• 18. Fachim HA, Loureiro CM, Corsi-Zuelli F et al. GRIN2B promoter methylation deficits in early-onset schizophrenia and its association with cognitive function. Epigenomics 11(4), 401–410 (2019).
  CASGoogle Scholar
• 19. Uno K, Kikuchi Y, Iwata M et al. Decreased DNA methylation in the Shati/Nat8l promoter in both patients with schizophrenia and a methamphetamine-induced murine model of schizophrenia-like phenotype. PLoS ONE 11(6), e0157959 (2016).
  MedlineGoogle Scholar
• 20. Lee SA, Huang KC. Epigenetic profiling of human brain differential DNA methylation networks in schizophrenia. BMC Med. Genomics. 9(Suppl. 3), 68 (2016).
  MedlineGoogle Scholar
• 21. Gaine ME, Seifuddin F, Sabunciyan S et al. Differentially methylated regions in bipolar disorder and suicide. Am. J Med. Genet. B Neuropsychiatr. Genet. 180(7), 496–507 (2019).
  Medline CASGoogle Scholar
• 22. Li S, Yang Q, Hou Y et al. Hypomethylation of LINE-1 elements in schizophrenia and bipolar disorder. J. Psychiatr. Res. 107, 68–72 (2018).
  MedlineGoogle Scholar
• 23. Li S, Zong L, Hou Y et al. Altered DNA methylation of the AluY subfamily in schizophrenia and bipolar disorder. Epigenomics 11(6), 581–586 (2019).
  CASGoogle Scholar
• 24. Sugawara H, Murata Y, Ikegame T et al. DNA methylation analyses of the candidate genes identified by a methylome-wide association study revealed common epigenetic alterations in schizophrenia and bipolar disorder. Psychiatry Clin. Neurosci. 72(4), 245–254 (2018).
  Medline CASGoogle Scholar
• 25. Hannon E, Dempster E, Viana J et al. An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation. Genome Biol. 17(1), 176 (2016). •• One of the largest genome-wide DNA methylation analysis of three cohorts suggesting polygenic nature of DNA methylation alterations in SCZ and bipolar disorder.
  MedlineGoogle Scholar
• 26. Siu MT, Butcher DT, Turinsky AL et al. Functional DNA methylation signatures for autism spectrum disorder genomic risk loci: 16p11.2 deletions and CHD8 variants. Clin. Epigenetics. 11(1), 103 (2019).
  Medline CASGoogle Scholar
• 27. Jia YF, Choi Y, Ayers-Ringler JR et al. Differential SLC1A2 promoter methylation in bipolar disorder with or without addiction. Front. Cell Neurosci. 11, 217 (2017).
  MedlineGoogle Scholar
• 28. Hu Z, Ying X, Huang L et al. Association of human serotonin receptor 4 promoter methylation with autism spectrum disorder. Medicine (Baltimore) 99(4), e18838 (2020).
  Medline CASGoogle Scholar
• 29. Siu MT, Goodman SJ, Yellan I et al. DNA Methylation of the Oxytocin Receptor Across Neurodevelopmental Disorders. J. Autism Dev. Disord. Doi: 10.1007/s10803-020-04792-x (2021) (Epub ahead of print).
  Google Scholar
• 30. Zhu Y, Mordaunt CE, Yasui DH et al. Placental DNA methylation levels at CYP2E1 and IRS2 are associated with child outcome in a prospective autism study. Hum. Mol. Genet. 28(16), 2659–2674 (2019).
  Medline CASGoogle Scholar
• 31. Walton E, Hass J, Liu J, Roffman JL et al. Correspondence of DNA methylation between blood and brain tissue and its application to schizophrenia research. Schizophr. Bull. 42(2), 406–414 (2016).
  MedlineGoogle Scholar
• 32. Backlund L, Wei YB, Martinsson L et al. Mood stabilizers and the influence on global leukocyte DNA methylation in bipolar disorder. Mol. Neuropsychiatry. 1(2), 76–81 (2015).
  Medline CASGoogle Scholar
• 33. Marie-Claire C, Lejeune FX, Mundwiller E et al. A DNA methylation signature discriminates between excellent and non-response to lithium in patients with bipolar disorder type 1. Sci. Rep. 10(1), 12239 (2020).
  Medline CASGoogle Scholar
• 34. Kaminsky Z, Jones I, Verma R et al. DNA methylation and expression of KCNQ3 in bipolar disorder. Bipolar Disord. 17(2), 150–159 (2015).
  Medline CASGoogle Scholar
• 35. Zhang HS, Ke XY, Hu LL, Wang J, Gao LS, Xie J. Study on the epigenetic methylation modification of bipolar disorder major genes. Eur. Rev. Med. Pharmacol. Sci. 22(5), 1421–1425 (2018).
  MedlineGoogle Scholar
• 36. Sabunciyan S, Maher B, Bahn S, Dickerson F, Yolken RH. Association of DNA methylation with acute mania and inflammatory markers. PLoS ONE 10(7), e0132001 (2015).
  MedlineGoogle Scholar
• 37. Abdolmaleky HM, Pajouhanfar S, Faghankhani M, Joghataie MT, Mostafavi A, Thiagalingam S. Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and bipolar disorder. Am. J Med. Genet. B Neuropsychiatr. Genet. 168, 687–696 (2015).
  Medline CASGoogle Scholar
• 38. Abdolmaleky HM, Nohesara S, Ghadirivasfi M et al. DNA hypermethylation of serotonin transporter gene promoter in drug naïve patients with schizophrenia. Schizophr. Res. 152(2–3), 373–380 (2014).
  MedlineGoogle Scholar
• 39. Ikegame T, Bundo M, Okada N et al. Promoter activity-based case-control association study on SLC6A4 highlighting hypermethylation and altered amygdala volume in male patients with schizophrenia. Schizophr. Bull. 46(6), 1577–1586 (2020).
  MedlineGoogle Scholar
• 40. Kinoshita M, Numata S, Tajima A et al. Effect of clozapine on DNA methylation in peripheral leukocytes from patients with treatment-resistant schizophrenia. Int. J. Mol. Sci. 18(3), 632 (2017).
  Google Scholar
• 41. Mak M, Samochowiec J, Frydecka D et al. First-episode schizophrenia is associated with a reduction of HERV-K methylation in peripheral blood. Psychiatry Res. 271, 459–463 (2019).
  Medline CASGoogle Scholar
• 42. Denomme MM, Haywood ME, Parks JC, Schoolcraft WB, Katz-Jaffe MG. The inherited methylome landscape is directly altered with paternal aging and associated with offspring neurodevelopmental disorders. Aging Cell 19(8), e13178 (2020).
  Medline CASGoogle Scholar
• 43. Fries GR, Bauer IE, Scaini G et al. Accelerated epigenetic aging and mitochondrial DNA copy number in bipolar disorder. Transl. Psychiatry. 7(12), 1283 (2017).
  MedlineGoogle Scholar
• 44. Hu Z, Gao S, Lindberg D et al. Temporal dynamics of miRNAs in human DLPFC and its association with miRNA dysregulation in schizophrenia. Transl. Psychiatry 9(1), 196 (2019).
  MedlineGoogle Scholar
• 45. Santarelli DM, Carroll AP, Cairns HM, Tooney PA, Cairns MJ. Schizophrenia-associated MicroRNA–gene interactions in the dorsolateral prefrontal cortex. Genomics Proteomics Bioinformatics 17(6), 623–634 (2019).
  MedlineGoogle Scholar
• 46. Amoah SK, Rodriguez BA, Logothetis CN et al. Exosomal secretion of a psychosis-altered miRNA that regulates glutamate receptor expression is affected by antipsychotics. Neuropsychopharmacology 45(4), 656–665 (2020).
  Medline CASGoogle Scholar
• 47. Zhao Z, Jinde S, Koike S et al. Altered expression of microRNA-223 in the plasma of patients with first-episode schizophrenia and its possible relation to neuronal migration-related genes. Transl. Psychiatry 9(1), 289 (2019).
  MedlineGoogle Scholar
• 48. Wang Y, Wang J, Guo T et al. Screening of schizophrenia associated miRNAs and the regulation of miR-320a-3p on integrin β1. Medicine (Baltimore) 98(8), e14332 (2019).
  Medline CASGoogle Scholar
• 49. Wei H, Yuan Y, Liu S et al. Detection of circulating miRNA levels in schizophrenia. Am. J. Psychiatry 172(11), 1141–1147 (2015). • One of relatively large studies proposing plasma biomarker for SCZ diagnosis.
  MedlineGoogle Scholar
• 50. He K, Guo C, Guo M et al. Identification of serum microRNAs as diagnostic biomarkers for schizophrenia. Hereditas 156, 23 (2019).
  MedlineGoogle Scholar
• 51. Du Y, Yu Y, Hu Y et al. Genome-wide, integrative analysis implicates exosome-derived MicroRNA dysregulation in schizophrenia. Schizophr. Bull. 45(6), 1257–1266 (2019).
  MedlineGoogle Scholar
• 52. Hauberg ME, Holm-Nielsen MH, Mattheisen M et al. Schizophrenia risk variants affecting microRNA function and site-specific regulation of NT5C2 by miR-206. Eur. Neuropsychopharmacol. 26(9), 1522–1526 (2016).
  Medline CASGoogle Scholar
• 53. Liu S, Zhang F, Wang X et al. Diagnostic value of blood-derived microRNAs for schizophrenia: results of a meta-analysis and validation. Sci. Rep. 7(1), 15328 (2017). • A meta-analysis of six studies introducing blood mononuclear miRNAs with high sensitivity and specificity for SCZ diagnosis.
  MedlineGoogle Scholar
• 54. Ma J, Shang S, Wang J et al. Identification of miR-22-3p, miR-92a-3p, and miR-137 in peripheral blood as biomarker for schizophrenia. Psychiatry Res. 265, 70–76 (2018).
  Medline CASGoogle Scholar
• 55. Liu YP, Meng JH, Wu X et al. Rs1625579 polymorphism in the MIR137 gene is associated with the risk of schizophrenia: updated meta-analysis. Neurosci. Lett. 713, 134535 (2019).
  Medline CASGoogle Scholar
• 56. He E, Lozano MAG, Stringer S et al. MIR137 schizophrenia-associated locus controls synaptic function by regulating synaptogenesis, synapse maturation and synaptic transmission. Hum. Mol. Genet. 27(11), 1879–1891 (2018).
  Medline CASGoogle Scholar
• 57. Thomas KT, Anderson BR, Shah N et al. Inhibition of the schizophrenia-associated MicroRNA miR-137 disrupts Nrg1α neurodevelopmental signal transduction. Cell Rep. 20(1), 1–12 (2017).
  Medline CASGoogle Scholar
• 58. de Sena Cortabitarte A, Berkel S, Cristian FB, Fischer C, Rappold GA. A direct regulatory link between microRNA-137 and SHANK2: implications for neuropsychiatric disorders. J. Neurodev. Disord. 10(1), 15 (2018).
  MedlineGoogle Scholar
• 59. Geaghan MP, Atkins JR, Brichta AM et al. Alteration of miRNA-mRNA interactions in lymphocytes of individuals with schizophrenia. J. Psychiatr. Res. 112, 89–98 (2019).
  MedlineGoogle Scholar
• 60. Cattane N, Mora C, Lopizzo N et al. Identification of a miRNAs signature associated with exposure to stress early in life and enhanced vulnerability for schizophrenia: new insights for the key role of miR-125b-1-3p in neurodevelopmental processes. Schizophr. Res. 205, 63–75 (2019).
  MedlineGoogle Scholar
• 61. Pala E, Denkçeken T. Evaluation of miRNA expression profiles in schizophrenia using principal-component analysis-based unsupervised feature extraction method. J. Comput. Biol. 27(8), 1253–1263 (2020).
  Medline CASGoogle Scholar
• 62. Choi JL, Kao PF, Itriago E et al. miR-149 and miR-29c as candidates for bipolar disorder biomarkers. Am. J. Med. Genet. B Neuropsychiatr. Genet. 174(3), 315–323 (2017).
  Medline CASGoogle Scholar
• 63. Banigan MG, Kao PF, Kozubek JA et al. Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients. PLoS ONE 8(1), e48814 (2013).
  Medline CASGoogle Scholar
• 64. Walker RM, Rybka J, Anderson SM et al. Preliminary investigation of miRNA expression in individuals at high familial risk of bipolar disorder. J. Psychiatr. Res. 62, 48–55 (2015).
  MedlineGoogle Scholar
• 65. Camkurt MA, Karababa İF, Erdal ME et al. MicroRNA dysregulation in manic and euthymic patients with bipolar disorder. J. Affect. Disord. 15(261), 84–90 (2020).
  Google Scholar
• 66. Tabano S, Caldiroli A, Terrasi A et al. A miRNome analysis of drug-free manic psychotic bipolar patients versus healthy controls. Eur. Arch. Psychiatry Clin. Neurosci. 270(7), 893–900 (2020).
  MedlineGoogle Scholar
• 67. Lee YC, Chao YL, Chang CE et al. Transcriptome changes in relation to manic episode. Front. Psychiatry. 10, 280 (2019).
  MedlineGoogle Scholar
• 68. Banach E, Dmitrzak-Weglarz M, Pawlak J et al. Dysregulation of miR-499, miR-708 and miR-1908 during a depression episode in bipolar disorders. Neurosci. Lett. 27(654), 117–119 (2017).
  Google Scholar
• 69. Forstner AJ, Hofmann A, Maaser A et al. Genome-wide analysis implicates microRNAs and their target genes in the development of bipolar disorder. Transl. Psychiatry 5(11), e678 (2015).
  Medline CASGoogle Scholar
• 70. Ceylan D, Tufekci KU, Keskinoglu P, Genc S, Özerdem A. Circulating exosomal microRNAs in bipolar disorder. J. Affect. Disord. 262, 99–107 (2020).
  Medline CASGoogle Scholar
• 71. Pisanu C, Merkouri Papadima E, Melis C et al. Whole genome expression analyses of miRNAs and mRNAs suggest the involvement of miR-320a and miR-155-3p and their targeted genes in lithium response in bipolar disorder. Int. J Mol. Sci. 20(23), 6040 (2019).
  CASGoogle Scholar
• 72. Camkurt MA, Acar S, Coskun S et al. Comparison of plasma MicroRNA levels in drug naive, first episode depressed patients and healthy controls. J. Psychiatr. Res. 69, 67–71 (2015).
  MedlineGoogle Scholar
• 73. Zhang HP, Liu XL, Chen JJ et al. Circulating microRNA 134 sheds light on the diagnosis of major depressive disorder. Transl. Psychiatry. 10(1), 95 (2020).
  Medline CASGoogle Scholar
• 74. Lee SY, Lu RB, Wang LJ et al. Serum miRNA as a possible biomarker in the diagnosis of bipolar II disorder. Sci. Rep. 10(1), 1131 (2020).
  Medline CASGoogle Scholar
• 75. Jyonouchi H, Geng L, Toruner GA, Rose S, Bennuri SC, Frye RE. Serum microRNAs in ASD: association with monocyte cytokine profiles and mitochondrial respiration. Front. Psychiatry 10(10), 614 (2019).
  MedlineGoogle Scholar
• 76. Hicks SD, Carpenter RL, Wagner KE et al. Saliva MicroRNA differentiates children with autism from peers with typical and atypical development. J. Am. Acad. Child Adolesc. Psychiatry 59(2), 296–308 (2020).
  MedlineGoogle Scholar
• 77. Yu D, Jiao X, Cao T, Huang F. Serum miRNA expression profiling reveals miR-486-3p may play a significant role in the development of autism by targeting ARID1B. Neuroreport 29(17), 1431–1436 (2018).
  Medline CASGoogle Scholar
• 78. Almehmadi KA, Tsilioni I, Theoharides TC. Increased expression of miR-155p5 in amygdala of children with autism spectrum disorder. Autism Res. 13(1), 18–23 (2020).
  MedlineGoogle Scholar
• 79. Nakata M, Kimura R, Funabiki Y, Awaya T, Murai T, Hagiwara M. MicroRNA profiling in adults with high-functioning autism spectrum disorder. Mol. Brain. 12(1), 82 (2019).
  MedlineGoogle Scholar
• 80. Pagan C, Goubran-Botros H, Delorme R et al. Disruption of melatonin synthesis is associated with impaired 14-3-3 and miR-451 levels in patients with autism spectrum disorders. Sci. Rep. 7(1), 2096 (2017).
  MedlineGoogle Scholar
• 81. Liang S, Li Z, Wang Y et al. Genome-wide DNA methylation analysis reveals epigenetic pattern of SH2B1 in Chinese monozygotic twins discordant for autism spectrum disorder. Front. Neurosci. 13, 712 (2019).
  MedlineGoogle Scholar
• 82. Mordaunt CE, Jianu JM, Laufer BI et al. Cord blood DNA methylome in newborns later diagnosed with autism spectrum disorder reflects early dysregulation of neurodevelopmental and X-linked genes. Genome Med. 12(1), 88 (2020).
  Medline CASGoogle Scholar
• 83. Wong CCY, Smith RG, Hannon E et al. Genome-wide DNA methylation profiling identifies convergent molecular signatures associated with idiopathic and syndromic autism in post-mortem human brain tissue. Hum. Mol. Genet. 28(13), 2201–2211 (2019).
  Medline CASGoogle Scholar
• 84. Hannon E, Schendel D, Ladd-Acosta C et al. Elevated polygenic burden for autism is associated with differential DNA methylation at birth. Genome Med. 10, 19 (2018). • A large-scale genome-wide DNA methylation analysis of blood samples indicating polygenic nature of DNA methylation alterations in autism.
  MedlineGoogle Scholar
• 85. Andrews SV, Sheppard B, Windham GC et al. Case–control meta-analysis of blood DNA methylation and autism spectrum disorder. Mol. Autism. 28(9), 40 (2018).
  Google Scholar
• 86. Wu YE, Parikshak NN, Belgard TG, Geschwind DH. Genome-wide, integrative analysis implicates microRNA dysregulation in autism spectrum disorder. Nat. Neurosci. 19(11), 1463–1476 (2016).
  Medline CASGoogle Scholar
• 87. Shen L, Lin Y, Sun Z, Yuan X, Chen L, Shen B. Knowledge-guided bioinformatics model for identifying autism spectrum disorder diagnostic MicroRNA biomarkers. Sci. Rep. 6, 39663 (2016).
  Medline CASGoogle Scholar
• 88. Mendizabal I, Berto S, Usui N et al. Cell type-specific epigenetic links to schizophrenia risk in the brain. Genome Biol. 20(1), 135 (2019).
  MedlineGoogle Scholar
• 89. Zhan L, Krabbe G, Du F et al. Proximal recolonization by self-renewing microglia re-establishes microglial homeostasis in the adult mouse brain. PLoS Biol. 17(2), e3000134 (2019).
  MedlineGoogle Scholar
• 90. Mendizabal I, Berto S, Usui N et al. Cell type-specific epigenetic links to schizophrenia risk in the brain. Genome Biol. 20(1), 135 (2019).
  MedlineGoogle Scholar
• 91. Wang G, Moffitt JR, Zhuang X. Multiplexed imaging of high-density libraries of RNAs with MERFISH and expansion microscopy. Sci. Rep. 8(1), 4847 (2018).
  MedlineGoogle Scholar
• 92. Merritt CR, Ong GT, Church SE et al. Multiplex digital spatial profiling of proteins and RNA in fixed tissue. Nat. Biotechnol. 38(5), 586–599 (2020).
  Medline CASGoogle Scholar
• 93. Hamshere ML, Walters JT, Smith R et al. Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol. Psychiatry 18(6), 708–712 (2013).
  Medline CASGoogle Scholar
• 94. Stahl EA, Breen G, Forstner AJ et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat. Genet. 51(5), 793–803 (2019).
  Medline CASGoogle Scholar
• 95. Collado MC, Rautava S, Aakko J, Isolauri E, Salminen S. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci. Rep. 6, 23129 (2016).
  Medline CASGoogle Scholar